Business
from24/7 Wall St.
3 weeks agoTeva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue
Pfizer's COVID-driven revenue decline contrasts with Teva's innovation-led acceleration and consecutive growth under a neuroscience-focused pivot.